Inflammatory Cascade Suppression is the clinical and therapeutic strategy focused on actively inhibiting or moderating the sequential release and activation of pro-inflammatory mediators and signaling molecules in the body. Chronic, low-grade systemic inflammation, often termed ‘inflammaging,’ is a key driver of age-related disease and metabolic dysfunction. Successful suppression aims to restore immune balance, reduce tissue damage, and improve overall cellular function by dampening the hyper-responsive inflammatory state.
Origin
This term is derived from immunology and pathology, where “inflammatory cascade” describes the rapid, amplified sequence of biochemical events following tissue injury or infection. “Suppression” in this context refers to the clinical modulation of this response, moving away from chronic pathology toward resolution and repair.
Mechanism
Suppression mechanisms involve the use of agents or interventions that stabilize cell membranes, inhibit the activation of key transcription factors like NF-kappaB, or block the production of pro-inflammatory cytokines, such as Interleukin-6 (IL-6) and Tumor Necrosis Factor-alpha (TNF-α). These actions promote a shift toward anti-inflammatory signaling pathways and increase the production of specialized pro-resolving mediators (SPMs), which actively resolve the inflammatory process and facilitate tissue healing.
We use cookies to personalize content and marketing, and to analyze our traffic. This helps us maintain the quality of our free resources. manage your preferences below.
Detailed Cookie Preferences
This helps support our free resources through personalized marketing efforts and promotions.
Analytics cookies help us understand how visitors interact with our website, improving user experience and website performance.
Personalization cookies enable us to customize the content and features of our site based on your interactions, offering a more tailored experience.